Concurrent GLP1R-agonist use with chemoimmunotherapy for early-stage triple-negative breast cancer. Comparison of methods with RNAscope using Pearson correlation and R².
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback